{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T17:47:16Z","timestamp":1777312036447,"version":"3.51.4"},"reference-count":32,"publisher":"Hamad bin Khalifa University Press (HBKU Press)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"abstract":"<jats:p>\n                    <jats:bold>Background:<\/jats:bold>\n                    Systemic lupus erythematosus (SLE) is a complex autoimmune disease with heterogeneous clinical presentations influenced by ethnicity, geography, and healthcare practices. This audit evaluated adherence to key quality indicators for SLE management at Hamad General Hospital (HGH), a major public tertiary care center in Doha, Qatar, in line with international standards.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods:<\/jats:bold>\n                    A retrospective cross-sectional audit was conducted between March and July 2024 involving 61 patients with SLE attending the rheumatology clinic at HGH. This audit assessed adherence to four selected key quality indicators: hydroxychloroquine (HCQ) use, annual proteinuria screening, annual ophthalmologic screening for HCQ-related retinopathy, and medication reconciliation documentation during the most recent clinic visit.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:<\/jats:bold>\n                    All patients were initiated on HCQ, with 11.5% discontinuing it due to adverse effects. Annual proteinuria screening was completed in 95% of patients. Ophthalmologic screening for HCQ-related retinopathy was documented in 65%, and medication reconciliation was completed in 72% of cases. The cohort represented a total of 21 nationalities, including Qataris who accounted for 31%\u2013a proportion higher than their estimated 11.6% representation in Qatar\u2019s national population.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion:<\/jats:bold>\n                    While adherence to HCQ initiation and renal monitoring met international benchmarks, ophthalmologic screening and medication reconciliation rates were suboptimal and required improvement. Targeted system-level and educational interventions are planned to enhance adherence to these standards. Re-audit following implementation will be essential to assess progress and to sustain the quality of care.\n                  <\/jats:p>","DOI":"10.5339\/qmj.2026.9","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T21:30:28Z","timestamp":1773696628000},"source":"Crossref","is-referenced-by-count":0,"title":["Systemic lupus erythematosus: Auditing standard of care in Qatar"],"prefix":"10.5339","volume":"2026","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-9621-1436","authenticated-orcid":true,"given":"Mohamad","family":"Safieh","sequence":"first","affiliation":[{"name":"Internal Medicine, Hamad General Hospital, Doha, Qatar"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdul-Wahab","family":"Al-Allaf","sequence":"additional","affiliation":[{"name":"Rheumatology, Hamad General Hospital, Doha, Qatar*Correspondance: Mohamad Safieh msafieh@hamad.qa"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3277","reference":[{"issue":"(6989):","key":"B1","series-title":"BMJ","first-page":"1257\u201361","article-title":"ABC of rheumatology. Systemic lupus erythematosus and lupus-like syndromes","volume":"310","author":"Hay\n \nEM","year":"1995"},{"issue":"(7):","key":"B2","series-title":"Arthritis Rheum","first-page":"1161\u201372","article-title":"Systemic lupus erythematosus in three ethnic groups: I. The effects of HLA class II, C4, and CR1 alleles, socioeconomic factors, and ethnicity at disease onset. LUMINA Study Group. Lupus in minority populations, nature versus nurture","volume":"41","author":"Reveille\n \nJD","year":"1998"},{"issue":"(4):","key":"B3","series-title":"Arch Rheumatol","first-page":"455\u201363","article-title":"Clinical and serologic characteristics of systemic lupus erythematosus in the Arab world: a pooled analysis of 3,273 patients","volume":"33","author":"Adwan\n \nM","year":"2018"},{"issue":"(1):","key":"B4","series-title":"Medicine (Baltimore)","first-page":"1\u201317","article-title":"on behalf of the Grupo Latinoamericano de Estudio del Lupus (GLADEL). The GLADEL multinational Latin American prospective inception cohort of 1,214 patients with systemic lupus erythematosus: ethnic and disease heterogeneity among \u201cHispanics\u201d","volume":"83","author":"Pons-Estel\n \nBA","year":"2004"},{"issue":"(5):","key":"B5","series-title":"Arthritis Care Res (Hoboken)","first-page":"622\u201329","article-title":"Racial and ethnic differences in the prevalence and time to onset of manifestations of systemic lupus erythematosus: the California Lupus Surveillance Project","volume":"72","author":"Maningding\n \nE","year":"2020"},{"issue":"(9):","key":"B6","series-title":"J Rheumatol","first-page":"1162\u20137","article-title":"Systemic lupus erythematosus in Iceland 1975 through 1984. A nationwide epidemiological study in an unselected population","volume":"17","author":"Gudmundsson\n \nS","year":"1990"},{"issue":"(4):","key":"B7","series-title":"Arthritis Rheum","first-page":"414\u20138","article-title":"High rate of death caused by systemic lupus erythematosus among U. S. residents of Asian descent","volume":"25","author":"Kaslow\n \nRA","year":"1982"},{"issue":"(2):","key":"B8","series-title":"Clin Rheumatol","first-page":"171\u20135","article-title":"Characterization of systemic lupus erythematosus in patients in U.A.E","volume":"14","author":"al-Attia\n \nHM","year":"1995"},{"issue":"(6):","key":"B9","series-title":"Cureus","first-page":"e41215","article-title":"Clinical manifestations of systemic lupus erythematosus in a Tertiary Center in Saudi Arabia","volume":"15","author":"AlOmair\n \nM","year":"2023"},{"issue":"(4):","key":"B10","series-title":"Rheumatol Int","first-page":"186\u201391","article-title":"Demographic, autoimmune, and clinical profiles of patients with systemic lupus erythematosus in Oman","volume":"23","author":"Al-Maini\n \nMH","year":"2003"},{"issue":"(11):","key":"B11","series-title":"Ann Rheum Dis","first-page":"1489\u2013501","article-title":"Management of systemic lupus erythematosus: a systematic literature review informing the 2023 update of the EULAR recommendations","volume":"83","author":"Kostopoulou\n \nM","year":"2024"},{"key":"B12","series-title":"Arthritis Care Res (Hoboken)","article-title":"2025 American College of Rheumatology (ACR) Guideline for the Treatment of Systemic Lupus Erythematosus","author":"Sammaritano\n \nLR","year":"2025"},{"key":"B13","series-title":"Qatar\u2019s expat landscape: 2024 population breakdown","author":"Qatar Moments","year":"2024"},{"issue":"(1):","key":"B14","series-title":"J Local Global Health Perspect","first-page":"2","article-title":"Tracking access, utilization and health system responsiveness to inform evidence-based health care policy: the case of Qatar","volume":"2015","author":"Hussin\n \nA","year":"2015"},{"issue":"(6):","key":"B15","series-title":"Ophthalmology","first-page":"1386\u201394","article-title":"American Academy of Ophthalmology. Recommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016 revision)","volume":"123","author":"Marmor\n \nMF","year":"2016"},{"issue":"(3):","key":"B16","series-title":"Cureus","first-page":"e56179","article-title":"Dermatologists\u2019 and rheumatologists\u2019 adherence to the latest recommendations for screening of hydroxychloroquine retinopathy in Saudi Arabia: a cross-sectional study","volume":"16","author":"Alghamdi\n \nAS","year":"2024"},{"issue":"(6989):","key":"B1","series-title":"BMJ","first-page":"1257\u201361","article-title":"ABC of rheumatology. Systemic lupus erythematosus and lupus-like syndromes","volume":"310","author":"Hay\n \nEM","year":"1995"},{"issue":"(7):","key":"B2","series-title":"Arthritis Rheum","first-page":"1161\u201372","article-title":"Systemic lupus erythematosus in three ethnic groups: I. The effects of HLA class II, C4, and CR1 alleles, socioeconomic factors, and ethnicity at disease onset. LUMINA Study Group. Lupus in minority populations, nature versus nurture","volume":"41","author":"Reveille\n \nJD","year":"1998"},{"issue":"(4):","key":"B3","series-title":"Arch Rheumatol","first-page":"455\u201363","article-title":"Clinical and serologic characteristics of systemic lupus erythematosus in the Arab world: a pooled analysis of 3,273 patients","volume":"33","author":"Adwan\n \nM","year":"2018"},{"issue":"(1):","key":"B4","series-title":"Medicine (Baltimore)","first-page":"1\u201317","article-title":"on behalf of the Grupo Latinoamericano de Estudio del Lupus (GLADEL). The GLADEL multinational Latin American prospective inception cohort of 1,214 patients with systemic lupus erythematosus: ethnic and disease heterogeneity among \u201cHispanics\u201d","volume":"83","author":"Pons-Estel\n \nBA","year":"2004"},{"issue":"(5):","key":"B5","series-title":"Arthritis Care Res (Hoboken)","first-page":"622\u201329","article-title":"Racial and ethnic differences in the prevalence and time to onset of manifestations of systemic lupus erythematosus: the California Lupus Surveillance Project","volume":"72","author":"Maningding\n \nE","year":"2020"},{"issue":"(9):","key":"B6","series-title":"J Rheumatol","first-page":"1162\u20137","article-title":"Systemic lupus erythematosus in Iceland 1975 through 1984. A nationwide epidemiological study in an unselected population","volume":"17","author":"Gudmundsson\n \nS","year":"1990"},{"issue":"(4):","key":"B7","series-title":"Arthritis Rheum","first-page":"414\u20138","article-title":"High rate of death caused by systemic lupus erythematosus among U. S. residents of Asian descent","volume":"25","author":"Kaslow\n \nRA","year":"1982"},{"issue":"(2):","key":"B8","series-title":"Clin Rheumatol","first-page":"171\u20135","article-title":"Characterization of systemic lupus erythematosus in patients in U.A.E","volume":"14","author":"al-Attia\n \nHM","year":"1995"},{"issue":"(6):","key":"B9","series-title":"Cureus","first-page":"e41215","article-title":"Clinical manifestations of systemic lupus erythematosus in a Tertiary Center in Saudi Arabia","volume":"15","author":"AlOmair\n \nM","year":"2023"},{"issue":"(4):","key":"B10","series-title":"Rheumatol Int","first-page":"186\u201391","article-title":"Demographic, autoimmune, and clinical profiles of patients with systemic lupus erythematosus in Oman","volume":"23","author":"Al-Maini\n \nMH","year":"2003"},{"issue":"(11):","key":"B11","series-title":"Ann Rheum Dis","first-page":"1489\u2013501","article-title":"Management of systemic lupus erythematosus: a systematic literature review informing the 2023 update of the EULAR recommendations","volume":"83","author":"Kostopoulou\n \nM","year":"2024"},{"key":"B12","series-title":"Arthritis Care Res (Hoboken)","article-title":"2025 American College of Rheumatology (ACR) Guideline for the Treatment of Systemic Lupus Erythematosus","author":"Sammaritano\n \nLR","year":"2025"},{"key":"B13","series-title":"Qatar\u2019s expat landscape: 2024 population breakdown","author":"Qatar Moments","year":"2024"},{"issue":"(1):","key":"B14","series-title":"J Local Global Health Perspect","first-page":"2","article-title":"Tracking access, utilization and health system responsiveness to inform evidence-based health care policy: the case of Qatar","volume":"2015","author":"Hussin\n \nA","year":"2015"},{"issue":"(6):","key":"B15","series-title":"Ophthalmology","first-page":"1386\u201394","article-title":"American Academy of Ophthalmology. Recommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016 revision)","volume":"123","author":"Marmor\n \nMF","year":"2016"},{"issue":"(3):","key":"B16","series-title":"Cureus","first-page":"e56179","article-title":"Dermatologists\u2019 and rheumatologists\u2019 adherence to the latest recommendations for screening of hydroxychloroquine retinopathy in Saudi Arabia: a cross-sectional study","volume":"16","author":"Alghamdi\n \nAS","year":"2024"}],"container-title":["Qatar Medical Journal"],"original-title":[],"link":[{"URL":"https:\/\/www.qscience.com\/view\/journals\/qmj\/2026\/1\/article-9.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.qscience.com\/downloadpdf\/journals\/qmj\/2026\/1\/article-9.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.qscience.com\/downloadpdf\/journals\/qmj\/2026\/1\/article-9.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T17:10:03Z","timestamp":1777309803000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.qscience.com\/view\/journals\/qmj\/2026\/1\/article-9.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":32,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.5339\/qmj.2026.9","relation":{},"ISSN":["2227-0426"],"issn-type":[{"value":"2227-0426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]}}}